Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Zolgensma (onasemnogene abeparvovec) Covered by Aetna (CVS Health) in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by Aetna in Pennsylvania Aetna covers Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy under strict prior authorization requiring: confirmed bi-allelic SMN1 mutations, age under 24 months, anti-AAV9 antibody titer ≤1:50, and treatment at an approved gene therapy center. If denied, you have 180 days

Denied Koselugo (Selumetinib) Coverage by Aetna CVS Health in New Jersey? Complete Appeal Guide with Forms and Templates

Answer Box: Getting Koselugo (Selumetinib) Covered by Aetna CVS Health in New Jersey Quick Path to Approval: Submit a complete prior authorization with NF1 diagnosis confirmation, imaging showing symptomatic plexiform neurofibromas, and documentation that surgery isn't feasible. If denied, file an internal appeal within 180 days, then use

How to Get Palynziq (pegvaliase-pqpz) Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Palynziq (pegvaliase-pqpz) covered by Aetna CVS Health in Ohio requires prior authorization with documented blood phenylalanine levels ≥600 µmol/L, evidence of sapropterin failure, and REMS enrollment. If denied, you have 180 days for internal appeal and 180 days for external review through Ohio Department of Insurance.

How to Get Fabrazyme (agalsidase beta) Covered by Aetna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Fabrazyme (agalsidase beta) requires prior authorization from Aetna in Washington. Your fastest path: 1) Have your specialist complete Aetna's PA form with genetic testing results and organ involvement documentation, 2) Submit via provider portal or fax, and 3) If denied, file internal appeal within 60-180 days,

How to Get Kanuma (Sebelipase Alfa) Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kanuma Approved by Aetna CVS Health in New York Fastest path to approval: Kanuma (sebelipase alfa) requires prior authorization from Aetna CVS Health. Success depends on confirming LAL deficiency with enzyme testing and genetic analysis, documenting disease severity (elevated ALT, hepatomegaly, dyslipidemia), and submitting through their specialty

Work With Your Doctor to Get Therakos CELLEX Photopheresis Approved by Aetna CVS Health in California

Answer Box: Your Path to Approval Getting Therakos CELLEX photopheresis covered by Aetna CVS Health in California requires strong physician partnership and detailed documentation. Start by scheduling a visit with your specialist to review your diagnosis (CTCL or steroid-refractory GVHD), document all failed prior treatments, and prepare a comprehensive medical

Get Tecentriq (Atezolizumab) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Your Fast Track to Tecentriq Coverage Getting Tecentriq (atezolizumab) covered by Aetna CVS Health in Virginia requires prior authorization with specific biomarker testing. Submit Aetna's Tecentriq precertification form with PD-L1 test results (≥1% for adjuvant NSCLC, ≥50% for first-line metastatic), negative EGFR/ALK mutation testing, and

Do You Qualify for Translarna (Ataluren) Coverage by Aetna CVS Health in California? Decision Tree & Next Steps

Answer Box: Getting Translarna (Ataluren) Covered by Aetna CVS Health in California Important Update: Translarna (ataluren) is currently under FDA review with no approved status in the United States as of 2025. While the FDA accepted PTC Therapeutics' resubmitted application in November 2024, no decision timeline has been set.

How to Get Givlaari (Givosiran) Covered by Aetna CVS Health in Washington: Complete Forms, Appeals Guide & Contact Numbers

Quick Answer: Getting Givlaari (Givosiran) Covered by Aetna CVS Health in Washington Path to approval: Submit Aetna's Givlaari precertification form with biochemical confirmation (elevated ALA/PBG levels), documented attack history (≥2 qualifying attacks in 6-12 months), and specialist evaluation. If denied, file internal appeal within 180 days, then

How to Get Tagrisso (Osimertinib) Covered by Aetna CVS Health in Michigan: Prior Authorization Forms, Appeals, and State Rights

Answer Box: Getting Tagrisso Covered by Aetna CVS Health in Michigan Fastest path to approval: Submit prior authorization with documented EGFR mutation test results, specific NSCLC diagnosis/stage, and prescriber attestation that Tagrisso meets FDA labeling criteria. Aetna typically requires 30-45 days for standard decisions, 72 hours for urgent oncology